Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Blade Therapeutics
442 Littlefield Avenue
South San Francisco, CA 94080
Phone: 650-278-4291
http://www.blademed.com/

Blade Therapeutics is a private biopharmaceutical company advancing novel anti-fibrotic therapies to meet important patient needs. Blade has assembled a critical mass of fibrosis expertise and a top-tier leadership team and world-class network of advisors with unparalleled experience in anti-fibrotic drug R&D. Blade 's lead program is a small molecule inhibitor targeting an intracellular cysteine protease that has been shown to be associated with fibrosis across diverse indications. The Company anticipates entering the clinic with its lead development candidate in mid-2018. For its foundational programs, Blade is leveraging insights from Johns Hopkins University School of Medicine (Laboratory of Hal Dietz, M.D.) to discover new therapeutic approaches that can broadly modulate fibrosis, and thereby contribute to the treatment of diverse diseases.

Key Contact
Name
Wendye Robbins
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
10/18/17 $45,000,000 Series B Bristol-Myers Squibb
Deerfield Management Company, L.P.
MPM Capital
Novartis Venture Funds
Osage University Partners
Pfizer Strategic Investments Group
undisclosed